We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study.
- Authors
Saltz, Leonard B; Lenz, Heinz-Josef; Kindler, Hedy L; Hochster, Howard S; Wadler, Scott; Hoff, Paulo M; Kemeny, Nancy E; Hollywood, Ellen M; Gonen, Mithat; Quinones, Marcus; Morse, Meroe; Chen, Helen X
- Abstract
We evaluated the safety and efficacy of concurrent administration of two monoclonal antibodies, cetuximab and bevacizumab, in patients with metastatic colorectal cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 29, p4557
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.12.0949